📌 Key findings:
✅ Females have a higher risk of heart failure but a lower risk of ventricular arrhythmias (VA) & atrial fibrillation (AF) compared to males.
✅ MYBPC3 variants may protect females from heart failure but not males.
✅ ESC risk scores may underestimate VA risk in females.

Women with HCM are often diagnosed later and face more severe disease than men, but why? 🤔 The reasons aren’t fully understood. What's clear, though, is that most clinical guidelines for HCM are based on research that predominantly includes male participants.

📖 Related work: bit.ly/41uqyj1

Another newbie here! I’m a clinical researcher and lab manager, with a focus on genetic heart disease and health disparities, based in Melbourne, Australia. Introducing my puppy, Rosie, my constant shadow 🐾🐶